Corden Pharma International

Corden Pharma International is a CMO/CDMO company operating in the pharmaceutical industry.

CordenPharma is a CDMO partner supporting biotech and pharma innovators of complex modalities in the advancement of their drug development lifecycle. Harnessing the collective expertise of the teams across its globally integrated facility network, CordenPharma provides bespoke outsourcing services spanning the complete supply chain, from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, CordenPharma provides customers high-value, end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid NanoParticles (LNPs), sterile Injectables, and the extensive supply of Small Molecules (both Highly Potent and Regular Potency). The CordenPharma Group is comprised of 12 facilities across Europe and North America. In the 2022 financial year, the organization generated sales of 870 million Euros and had over 3,000 employees. Please visit cordenpharma.com for more information.

Company type

CMO/CDMO

Products and services

Custom Manufacturing, Finished Dosage Forms, Pharmaceutical Packaging, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services

Markets

Oceania, North America (USA, Canada), Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Useful Links

Connect with Corden Pharma International on LinkedIn

Address

Corden Pharma International, Otto-Hahn-Strasse, Plankstadt, Germany, 68723